The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

The S&P 500 added 1% on Friday, June 6, as a strong jobs report pointed to resilience in the labor market despite ...

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

It has been about a month since the last earnings report for Mirum Pharmaceuticals, Inc. (MIRM). Shares have lost about 1.3% in that time frame, underperforming the S&P 500. Will the recent negative ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...